Shikonin Reduces Growth of Docetaxel-Resistant Prostate Cancer Cells Mainly through Necroptosis

SIMPLE SUMMARY: Prostate carcinoma (PCa) is the most common tumor in men with an increasing age-associated risk. Several therapy strategies, one of which is docetaxel (DX) chemotherapy, have been established. However, due to the development of therapy resistance, in which chemotherapy no longer effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Markowitsch, Sascha D., Juetter, Kira M., Schupp, Patricia, Hauschulte, Kristine, Vakhrusheva, Olesya, Slade, Kimberly Sue, Thomas, Anita, Tsaur, Igor, Cinatl, Jindrich, Michaelis, Martin, Efferth, Thomas, Haferkamp, Axel, Juengel, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923752/
https://www.ncbi.nlm.nih.gov/pubmed/33672520
http://dx.doi.org/10.3390/cancers13040882

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923752/
https://www.ncbi.nlm.nih.gov/pubmed/33672520
http://dx.doi.org/10.3390/cancers13040882

Ejemplares similares